Hyderabad, Feb 26 (PTI) Telangana Chief Minister A Revanth Reddy on Thursday said the state government will introduce legislation in the upcoming budget session of the Assembly to deduct 10-15 per ...

The Central Consumer Protection Authority (CCPA) has passed a final order imposing a penalty of ₹15 lakh on Vajirao and Reddy Institute for issuing misleading result advertisements in relation to the ...

It was fined for publishing misleading advertisements claiming credit for candidates who cleared the UPSC in 2023 when they enrolled only for mock interview sessions.

Dr Reddy’s Laboratories has entered into a definitive agreement to acquire the India trademarks and related assets of two hormone replacement therapy (HRT) brands, Progynova and Cyclo-Progynova, from ...

The Supreme Court on Tuesday dismissed appeals in the 2002 death case of actress Prathyusha, ruling out murder and affirming Gudipalli Siddhartha Reddy’s conviction for abetment of suicide. Reddy ...

A massive 15-foot python causes chaos after escaping inside a home. Rock the Country festival: Artists dropping out amid Kid Rock controversy Judge extends block on Trump admin’s bid to slash social ...

Abstract: Bayesian inference provides a methodology for parameter estimation and uncertainty quantification in machine learning and deep learning methods. Variational inference and Markov Chain ...

A Florida snake hunter, his wife, and their two kids were able to wrestle and take out a whopping 202-pound Burmese python in a battle that saw the slithering beast drag the professional some 15 feet ...

A professional python hunter in Florida needed assistance from family members to uncoil a giant Burmese python from his body and to ultimately subdue the second-heaviest python ever caught in Florida.

HYDERABAD, Jan 21 (Reuters) - Indian drugmaker Dr Reddy's (REDY.NS), opens new tab, which reported a smaller-than-expected fall in quarterly profit on Wednesday, said that it has received an approval ...

Dr. Reddy’s Laboratories is paying $20 million upfront for the rights to Immutep’s phase 3-stage LAG-3 candidate in certain territories while leaving the Australian biotech with ownership in key ...